(Q36404495)

14 August 2017

1 reference

title

Physiological and pathophysiological regulation of regional adipose tissue in the development of insulin resistance and type 2 diabetes (English)

1 reference

14 August 2017

1 reference

1 reference

1 reference

Rattarasarn C

1

1 reference

14 August 2017

publication date

1 February 2006

1 reference

14 August 2017

1 reference

14 August 2017

volume

186

1 reference

14 August 2017

issue

2

1 reference

14 August 2017

page(s)

87-101

1 reference

Decreased plasma adiponectin concentrations are closely related to hepatic fat content and hepatic insulin resistance in pioglitazone-treated type 2 diabetic patients

14 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2005.01521.X

The adipocyte-secreted protein Acrp30 enhances hepatic insulin action

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2005.01521.X

Non-esterified fatty acids and the liver: why is insulin secreted into the portal vein?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2005.01521.X

Acute regulation of adiponectin by free fatty acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2005.01521.X

Adiponectin receptors gene expression and insulin sensitivity in non-diabetic Mexican Americans with or without a family history of Type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2005.01521.X

Impaired glucose transport as a cause of decreased insulin-stimulated muscle glycogen synthesis in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2005.01521.X

Efficacy of recombinant methionyl human leptin therapy for the extreme insulin resistance of the Rabson-Mendenhall syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2005.01521.X

Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2005.01521.X

RETRACTED: Visfatin: a protein secreted by visceral fat that mimics the effects of insulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2005.01521.X

Serum resistin levels of obese and lean children and adolescents: biochemical analysis and clinical relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2005.01521.X

Congenital leptin deficiency due to homozygosity for the Delta133G mutation: report of another case and evaluation of response to four years of leptin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2005.01521.X

Relationship between serum resistin concentrations and insulin resistance in nonobese, obese, and obese diabetic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2005.01521.X

Adipose tissue adiponectin production and adiponectin serum concentration in human obesity and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2005.01521.X

Regional uptake of meal fatty acids in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2005.01521.X

Fat distribution, lipid accumulation in the liver, and exercise capacity do not explain the insulin resistance in healthy males with a family history for type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2005.01521.X

Fatty liver in type 2 diabetes mellitus: relation to regional adiposity, fatty acids, and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2005.01521.X

Absence of an effect of liposuction on insulin action and risk factors for coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2005.01521.X

PPAR alpha is necessary for the lipopenic action of hyperleptinemia on white adipose and liver tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2005.01521.X

Adiponectin: action, regulation and association to insulin sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2005.01521.X

Rosiglitazone prevents the impairment of human islet function induced by fatty acids: evidence for a role of PPARgamma2 in the modulation of insulin secretion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2005.01521.X

Intramyocellular lipids and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2005.01521.X

Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2005.01521.X

Abdominal fat distribution and peripheral and hepatic insulin resistance in type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2005.01521.X

Complex distribution, not absolute amount of adiponectin, correlates with thiazolidinedione-mediated improvement in insulin sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2005.01521.X

Insulin resistance, intramyocellular lipid content, and plasma adiponectin in patients with type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2005.01521.X

Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2005.01521.X

Gender differences of regional abdominal fat distribution and their relationships with insulin sensitivity in healthy and glucose-intolerant Thais

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2005.01521.X

Abdominal adiposity and insulin resistance in obese men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2005.01521.X

Beneficial effects of tumor necrosis factor-alpha inhibition by pentoxifylline on clinical, biochemical, and metabolic parameters of patients with nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2005.01521.X

A Novel Serum Protein Similar to C1q, Produced Exclusively in Adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2005.01521.X

Contributions of total body fat, abdominal subcutaneous adipose tissue compartments, and visceral adipose tissue to the metabolic complications of obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2005.01521.X

Human serum adiponectin levels are not under short-term negative control by free fatty acids in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2005.01521.X

ACRP30, a new hormone controlling fat and glucose metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2005.01521.X

Insulin/Foxo1 pathway regulates expression levels of adiponectin receptors and adiponectin sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2005.01521.X

Longevity, lipotoxicity and leptin: the adipocyte defense against feasting and famine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2005.01521.X

Single-nucleotide polymorphism haplotypes in the both proximal promoter and exon 3 of the APM1 gene modulate adipocyte-secreted adiponectin hormone levels and contribute to the genetic risk for type 2 diabetes in French Caucasians

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2005.01521.X

Impaired multimerization of human adiponectin mutants associated with diabetes. Molecular structure and multimer formation of adiponectin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2005.01521.X

Low adiponectin levels in adolescent obesity: a marker of increased intramyocellular lipid accumulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2005.01521.X

The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2005.01521.X

The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2005.01521.X

Cloning of adiponectin receptors that mediate antidiabetic metabolic effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2005.01521.X

Uncoupling protein 3 as a mitochondrial fatty acid anion exporter

21 January 2018

1 reference

12 August 2022

https://opencitations.net/index/coci/api/v1/citations/10.1096/FJ.03-0515FJE

Identifiers

DOI

10.1111/J.1748-1716.2005.01521.X

1 reference

14 August 2017

1 reference